nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HRH1—Dimenhydrinate—atopic dermatitis	0.239	0.411	CbGbCtD
Zuclopenthixol—HRH1—Loratadine—atopic dermatitis	0.117	0.201	CbGbCtD
Zuclopenthixol—HRH1—Diphenhydramine—atopic dermatitis	0.117	0.201	CbGbCtD
Zuclopenthixol—CYP2D6—Loratadine—atopic dermatitis	0.0466	0.0801	CbGbCtD
Zuclopenthixol—CYP2D6—Diphenhydramine—atopic dermatitis	0.0466	0.0801	CbGbCtD
Zuclopenthixol—DRD5—eyelid—atopic dermatitis	0.0302	0.736	CbGeAlD
Zuclopenthixol—CYP2D6—Dexamethasone—atopic dermatitis	0.0161	0.0277	CbGbCtD
Zuclopenthixol—HTR6—head—atopic dermatitis	0.00196	0.0478	CbGeAlD
Zuclopenthixol—DRD5—head—atopic dermatitis	0.00191	0.0465	CbGeAlD
Zuclopenthixol—DRD1—head—atopic dermatitis	0.00146	0.0355	CbGeAlD
Zuclopenthixol—HTR2A—neck—atopic dermatitis	0.00135	0.0328	CbGeAlD
Zuclopenthixol—ADRA1A—head—atopic dermatitis	0.000879	0.0214	CbGeAlD
Zuclopenthixol—DRD2—head—atopic dermatitis	0.000862	0.021	CbGeAlD
Zuclopenthixol—HRH1—head—atopic dermatitis	0.00068	0.0166	CbGeAlD
Zuclopenthixol—ADRA2A—head—atopic dermatitis	0.000668	0.0163	CbGeAlD
Zuclopenthixol—HTR2A—head—atopic dermatitis	0.000568	0.0138	CbGeAlD
Zuclopenthixol—CYP2D6—head—atopic dermatitis	0.000518	0.0126	CbGeAlD
Zuclopenthixol—Hypertension—Hydrocortisone—atopic dermatitis	0.000208	0.00065	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisolone—atopic dermatitis	0.000207	0.000648	CcSEcCtD
Zuclopenthixol—Erythema—Dexamethasone—atopic dermatitis	0.000205	0.000643	CcSEcCtD
Zuclopenthixol—Erythema—Betamethasone—atopic dermatitis	0.000205	0.000643	CcSEcCtD
Zuclopenthixol—Myalgia—Hydrocortisone—atopic dermatitis	0.000205	0.000641	CcSEcCtD
Zuclopenthixol—Malaise—Triamcinolone—atopic dermatitis	0.000204	0.000639	CcSEcCtD
Zuclopenthixol—Anxiety—Hydrocortisone—atopic dermatitis	0.000204	0.000639	CcSEcCtD
Zuclopenthixol—Malaise—Methylprednisolone—atopic dermatitis	0.000204	0.000638	CcSEcCtD
Zuclopenthixol—Vertigo—Triamcinolone—atopic dermatitis	0.000203	0.000637	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000203	0.000636	CcSEcCtD
Zuclopenthixol—Syncope—Triamcinolone—atopic dermatitis	0.000203	0.000636	CcSEcCtD
Zuclopenthixol—Vertigo—Methylprednisolone—atopic dermatitis	0.000203	0.000635	CcSEcCtD
Zuclopenthixol—Syncope—Methylprednisolone—atopic dermatitis	0.000203	0.000634	CcSEcCtD
Zuclopenthixol—Discomfort—Hydrocortisone—atopic dermatitis	0.000202	0.000633	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Prednisone—atopic dermatitis	0.000202	0.000632	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000201	0.000629	CcSEcCtD
Zuclopenthixol—Vomiting—Tacrolimus—atopic dermatitis	0.0002	0.000626	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000199	0.000623	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000199	0.000621	CcSEcCtD
Zuclopenthixol—Rash—Tacrolimus—atopic dermatitis	0.000198	0.000621	CcSEcCtD
Zuclopenthixol—Dermatitis—Tacrolimus—atopic dermatitis	0.000198	0.00062	CcSEcCtD
Zuclopenthixol—Shock—Prednisolone—atopic dermatitis	0.000198	0.000619	CcSEcCtD
Zuclopenthixol—Headache—Tacrolimus—atopic dermatitis	0.000197	0.000617	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000196	0.000614	CcSEcCtD
Zuclopenthixol—Convulsion—Triamcinolone—atopic dermatitis	0.000196	0.000614	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisolone—atopic dermatitis	0.000196	0.000614	CcSEcCtD
Zuclopenthixol—Convulsion—Methylprednisolone—atopic dermatitis	0.000196	0.000613	CcSEcCtD
Zuclopenthixol—Hypertension—Triamcinolone—atopic dermatitis	0.000196	0.000612	CcSEcCtD
Zuclopenthixol—Hypertension—Methylprednisolone—atopic dermatitis	0.000195	0.00061	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000194	0.000608	CcSEcCtD
Zuclopenthixol—Shock—Hydrocortisone—atopic dermatitis	0.000193	0.000604	CcSEcCtD
Zuclopenthixol—Myalgia—Triamcinolone—atopic dermatitis	0.000193	0.000603	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000193	0.000602	CcSEcCtD
Zuclopenthixol—Myalgia—Methylprednisolone—atopic dermatitis	0.000192	0.000602	CcSEcCtD
Zuclopenthixol—Eye disorder—Prednisone—atopic dermatitis	0.000192	0.000601	CcSEcCtD
Zuclopenthixol—Anxiety—Methylprednisolone—atopic dermatitis	0.000192	0.0006	CcSEcCtD
Zuclopenthixol—Tachycardia—Hydrocortisone—atopic dermatitis	0.000192	0.0006	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000191	0.000598	CcSEcCtD
Zuclopenthixol—Skin disorder—Hydrocortisone—atopic dermatitis	0.000191	0.000597	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000191	0.000597	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000191	0.000597	CcSEcCtD
Zuclopenthixol—Discomfort—Triamcinolone—atopic dermatitis	0.00019	0.000596	CcSEcCtD
Zuclopenthixol—Discomfort—Methylprednisolone—atopic dermatitis	0.00019	0.000595	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.00019	0.000594	CcSEcCtD
Zuclopenthixol—Dry mouth—Triamcinolone—atopic dermatitis	0.000189	0.00059	CcSEcCtD
Zuclopenthixol—Anorexia—Hydrocortisone—atopic dermatitis	0.000187	0.000586	CcSEcCtD
Zuclopenthixol—Nausea—Tacrolimus—atopic dermatitis	0.000187	0.000585	CcSEcCtD
Zuclopenthixol—Angiopathy—Prednisone—atopic dermatitis	0.000187	0.000584	CcSEcCtD
Zuclopenthixol—Immune system disorder—Prednisone—atopic dermatitis	0.000186	0.000581	CcSEcCtD
Zuclopenthixol—Malaise—Betamethasone—atopic dermatitis	0.000185	0.00058	CcSEcCtD
Zuclopenthixol—Malaise—Dexamethasone—atopic dermatitis	0.000185	0.00058	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000185	0.000578	CcSEcCtD
Zuclopenthixol—Vertigo—Betamethasone—atopic dermatitis	0.000185	0.000578	CcSEcCtD
Zuclopenthixol—Vertigo—Dexamethasone—atopic dermatitis	0.000185	0.000578	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000184	0.000577	CcSEcCtD
Zuclopenthixol—Syncope—Betamethasone—atopic dermatitis	0.000184	0.000577	CcSEcCtD
Zuclopenthixol—Syncope—Dexamethasone—atopic dermatitis	0.000184	0.000577	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisone—atopic dermatitis	0.000184	0.000575	CcSEcCtD
Zuclopenthixol—Hypotension—Hydrocortisone—atopic dermatitis	0.000183	0.000574	CcSEcCtD
Zuclopenthixol—Shock—Triamcinolone—atopic dermatitis	0.000182	0.000569	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisolone—atopic dermatitis	0.000182	0.000569	CcSEcCtD
Zuclopenthixol—Shock—Methylprednisolone—atopic dermatitis	0.000181	0.000568	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000181	0.000566	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000181	0.000565	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Betamethasone—atopic dermatitis	0.000181	0.000565	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisolone—atopic dermatitis	0.00018	0.000565	CcSEcCtD
Zuclopenthixol—Tachycardia—Triamcinolone—atopic dermatitis	0.00018	0.000564	CcSEcCtD
Zuclopenthixol—Mental disorder—Prednisone—atopic dermatitis	0.00018	0.000564	CcSEcCtD
Zuclopenthixol—Tachycardia—Methylprednisolone—atopic dermatitis	0.00018	0.000563	CcSEcCtD
Zuclopenthixol—Skin disorder—Methylprednisolone—atopic dermatitis	0.000179	0.000561	CcSEcCtD
Zuclopenthixol—Malnutrition—Prednisone—atopic dermatitis	0.000179	0.00056	CcSEcCtD
Zuclopenthixol—Erythema—Prednisone—atopic dermatitis	0.000179	0.00056	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000179	0.00056	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000179	0.000559	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000178	0.000558	CcSEcCtD
Zuclopenthixol—Convulsion—Betamethasone—atopic dermatitis	0.000178	0.000557	CcSEcCtD
Zuclopenthixol—Convulsion—Dexamethasone—atopic dermatitis	0.000178	0.000557	CcSEcCtD
Zuclopenthixol—Insomnia—Hydrocortisone—atopic dermatitis	0.000178	0.000556	CcSEcCtD
Zuclopenthixol—Hypertension—Dexamethasone—atopic dermatitis	0.000177	0.000555	CcSEcCtD
Zuclopenthixol—Hypertension—Betamethasone—atopic dermatitis	0.000177	0.000555	CcSEcCtD
Zuclopenthixol—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000176	0.000552	CcSEcCtD
Zuclopenthixol—Myalgia—Dexamethasone—atopic dermatitis	0.000175	0.000547	CcSEcCtD
Zuclopenthixol—Myalgia—Betamethasone—atopic dermatitis	0.000175	0.000547	CcSEcCtD
Zuclopenthixol—Anxiety—Dexamethasone—atopic dermatitis	0.000174	0.000546	CcSEcCtD
Zuclopenthixol—Anxiety—Betamethasone—atopic dermatitis	0.000174	0.000546	CcSEcCtD
Zuclopenthixol—Discomfort—Betamethasone—atopic dermatitis	0.000173	0.000541	CcSEcCtD
Zuclopenthixol—Discomfort—Dexamethasone—atopic dermatitis	0.000173	0.000541	CcSEcCtD
Zuclopenthixol—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000173	0.000541	CcSEcCtD
Zuclopenthixol—Hypotension—Methylprednisolone—atopic dermatitis	0.000172	0.000539	CcSEcCtD
Zuclopenthixol—Pain—Prednisolone—atopic dermatitis	0.000172	0.000538	CcSEcCtD
Zuclopenthixol—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000171	0.000534	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000169	0.00053	CcSEcCtD
Zuclopenthixol—Fatigue—Hydrocortisone—atopic dermatitis	0.000169	0.00053	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisone—atopic dermatitis	0.000169	0.000528	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000168	0.000527	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000168	0.000526	CcSEcCtD
Zuclopenthixol—Pain—Hydrocortisone—atopic dermatitis	0.000168	0.000525	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000168	0.000525	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000168	0.000525	CcSEcCtD
Zuclopenthixol—Insomnia—Triamcinolone—atopic dermatitis	0.000167	0.000523	CcSEcCtD
Zuclopenthixol—Insomnia—Methylprednisolone—atopic dermatitis	0.000167	0.000522	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Prednisone—atopic dermatitis	0.000166	0.00052	CcSEcCtD
Zuclopenthixol—Paraesthesia—Triamcinolone—atopic dermatitis	0.000166	0.000519	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisolone—atopic dermatitis	0.000166	0.000518	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000166	0.000518	CcSEcCtD
Zuclopenthixol—Shock—Betamethasone—atopic dermatitis	0.000165	0.000516	CcSEcCtD
Zuclopenthixol—Shock—Dexamethasone—atopic dermatitis	0.000165	0.000516	CcSEcCtD
Zuclopenthixol—Dyspnoea—Triamcinolone—atopic dermatitis	0.000165	0.000516	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000164	0.000515	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Betamethasone—atopic dermatitis	0.000164	0.000515	CcSEcCtD
Zuclopenthixol—Agitation—Prednisone—atopic dermatitis	0.000164	0.000515	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000164	0.000514	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000164	0.000514	CcSEcCtD
Zuclopenthixol—Tachycardia—Betamethasone—atopic dermatitis	0.000164	0.000512	CcSEcCtD
Zuclopenthixol—Tachycardia—Dexamethasone—atopic dermatitis	0.000164	0.000512	CcSEcCtD
Zuclopenthixol—Dyspepsia—Triamcinolone—atopic dermatitis	0.000163	0.000509	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000162	0.000508	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000162	0.000507	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000162	0.000507	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000162	0.000506	CcSEcCtD
Zuclopenthixol—Malaise—Prednisone—atopic dermatitis	0.000161	0.000505	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisone—atopic dermatitis	0.000161	0.000503	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000161	0.000502	CcSEcCtD
Zuclopenthixol—Syncope—Prednisone—atopic dermatitis	0.00016	0.000502	CcSEcCtD
Zuclopenthixol—Anorexia—Betamethasone—atopic dermatitis	0.00016	0.0005	CcSEcCtD
Zuclopenthixol—Anorexia—Dexamethasone—atopic dermatitis	0.00016	0.0005	CcSEcCtD
Zuclopenthixol—Fatigue—Triamcinolone—atopic dermatitis	0.000159	0.000499	CcSEcCtD
Zuclopenthixol—Fatigue—Methylprednisolone—atopic dermatitis	0.000159	0.000498	CcSEcCtD
Zuclopenthixol—Pain—Triamcinolone—atopic dermatitis	0.000158	0.000495	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Prednisone—atopic dermatitis	0.000157	0.000492	CcSEcCtD
Zuclopenthixol—Hypotension—Dexamethasone—atopic dermatitis	0.000157	0.00049	CcSEcCtD
Zuclopenthixol—Hypotension—Betamethasone—atopic dermatitis	0.000157	0.00049	CcSEcCtD
Zuclopenthixol—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000155	0.000486	CcSEcCtD
Zuclopenthixol—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000155	0.000486	CcSEcCtD
Zuclopenthixol—Convulsion—Prednisone—atopic dermatitis	0.000155	0.000485	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisone—atopic dermatitis	0.000155	0.000483	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000153	0.000478	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000153	0.000478	CcSEcCtD
Zuclopenthixol—Myalgia—Prednisone—atopic dermatitis	0.000152	0.000477	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000152	0.000477	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000152	0.000476	CcSEcCtD
Zuclopenthixol—Anxiety—Prednisone—atopic dermatitis	0.000152	0.000475	CcSEcCtD
Zuclopenthixol—Insomnia—Dexamethasone—atopic dermatitis	0.000152	0.000475	CcSEcCtD
Zuclopenthixol—Insomnia—Betamethasone—atopic dermatitis	0.000152	0.000475	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000151	0.000473	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000151	0.000472	CcSEcCtD
Zuclopenthixol—Paraesthesia—Betamethasone—atopic dermatitis	0.000151	0.000471	CcSEcCtD
Zuclopenthixol—Paraesthesia—Dexamethasone—atopic dermatitis	0.000151	0.000471	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisone—atopic dermatitis	0.000151	0.000471	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisolone—atopic dermatitis	0.000148	0.000463	CcSEcCtD
Zuclopenthixol—Dyspepsia—Betamethasone—atopic dermatitis	0.000148	0.000462	CcSEcCtD
Zuclopenthixol—Dyspepsia—Dexamethasone—atopic dermatitis	0.000148	0.000462	CcSEcCtD
Zuclopenthixol—Body temperature increased—Triamcinolone—atopic dermatitis	0.000146	0.000457	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisone—atopic dermatitis	0.000146	0.000457	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000146	0.000456	CcSEcCtD
Zuclopenthixol—Decreased appetite—Betamethasone—atopic dermatitis	0.000146	0.000456	CcSEcCtD
Zuclopenthixol—Decreased appetite—Dexamethasone—atopic dermatitis	0.000146	0.000456	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000145	0.000453	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000145	0.000453	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000145	0.000453	CcSEcCtD
Zuclopenthixol—Fatigue—Dexamethasone—atopic dermatitis	0.000145	0.000452	CcSEcCtD
Zuclopenthixol—Fatigue—Betamethasone—atopic dermatitis	0.000145	0.000452	CcSEcCtD
Zuclopenthixol—Shock—Prednisone—atopic dermatitis	0.000144	0.00045	CcSEcCtD
Zuclopenthixol—Pain—Dexamethasone—atopic dermatitis	0.000143	0.000449	CcSEcCtD
Zuclopenthixol—Pain—Betamethasone—atopic dermatitis	0.000143	0.000449	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Prednisone—atopic dermatitis	0.000143	0.000448	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisone—atopic dermatitis	0.000143	0.000446	CcSEcCtD
Zuclopenthixol—Skin disorder—Prednisone—atopic dermatitis	0.000142	0.000444	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisone—atopic dermatitis	0.000141	0.000442	CcSEcCtD
Zuclopenthixol—Asthenia—Hydrocortisone—atopic dermatitis	0.000141	0.000441	CcSEcCtD
Zuclopenthixol—Anorexia—Prednisone—atopic dermatitis	0.000139	0.000436	CcSEcCtD
Zuclopenthixol—Pruritus—Hydrocortisone—atopic dermatitis	0.000139	0.000435	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Betamethasone—atopic dermatitis	0.000138	0.000432	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000138	0.000432	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000137	0.000429	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000137	0.000429	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000136	0.000426	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000136	0.000425	CcSEcCtD
Zuclopenthixol—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000134	0.00042	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000133	0.000416	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisolone—atopic dermatitis	0.000133	0.000416	CcSEcCtD
Zuclopenthixol—Asthenia—Triamcinolone—atopic dermatitis	0.000133	0.000415	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dexamethasone—atopic dermatitis	0.000133	0.000415	CcSEcCtD
Zuclopenthixol—Body temperature increased—Betamethasone—atopic dermatitis	0.000133	0.000415	CcSEcCtD
Zuclopenthixol—Abdominal pain—Betamethasone—atopic dermatitis	0.000133	0.000415	CcSEcCtD
Zuclopenthixol—Body temperature increased—Dexamethasone—atopic dermatitis	0.000133	0.000415	CcSEcCtD
Zuclopenthixol—Asthenia—Methylprednisolone—atopic dermatitis	0.000132	0.000414	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisone—atopic dermatitis	0.000132	0.000413	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisone—atopic dermatitis	0.000131	0.00041	CcSEcCtD
Zuclopenthixol—Pruritus—Triamcinolone—atopic dermatitis	0.000131	0.000409	CcSEcCtD
Zuclopenthixol—Pruritus—Methylprednisolone—atopic dermatitis	0.00013	0.000408	CcSEcCtD
Zuclopenthixol—Dizziness—Hydrocortisone—atopic dermatitis	0.00013	0.000406	CcSEcCtD
Zuclopenthixol—Dyspepsia—Prednisone—atopic dermatitis	0.000129	0.000402	CcSEcCtD
Zuclopenthixol—Decreased appetite—Prednisone—atopic dermatitis	0.000127	0.000397	CcSEcCtD
Zuclopenthixol—Rash—Prednisolone—atopic dermatitis	0.000127	0.000397	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisolone—atopic dermatitis	0.000127	0.000396	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000126	0.000395	CcSEcCtD
Zuclopenthixol—Fatigue—Prednisone—atopic dermatitis	0.000126	0.000394	CcSEcCtD
Zuclopenthixol—Headache—Prednisolone—atopic dermatitis	0.000126	0.000394	CcSEcCtD
Zuclopenthixol—Constipation—Prednisone—atopic dermatitis	0.000125	0.000391	CcSEcCtD
Zuclopenthixol—Vomiting—Hydrocortisone—atopic dermatitis	0.000125	0.000391	CcSEcCtD
Zuclopenthixol—Rash—Hydrocortisone—atopic dermatitis	0.000124	0.000387	CcSEcCtD
Zuclopenthixol—Dermatitis—Hydrocortisone—atopic dermatitis	0.000124	0.000387	CcSEcCtD
Zuclopenthixol—Headache—Hydrocortisone—atopic dermatitis	0.000123	0.000385	CcSEcCtD
Zuclopenthixol—Dizziness—Triamcinolone—atopic dermatitis	0.000122	0.000382	CcSEcCtD
Zuclopenthixol—Dizziness—Methylprednisolone—atopic dermatitis	0.000122	0.000382	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisone—atopic dermatitis	0.00012	0.000377	CcSEcCtD
Zuclopenthixol—Asthenia—Dexamethasone—atopic dermatitis	0.00012	0.000377	CcSEcCtD
Zuclopenthixol—Asthenia—Betamethasone—atopic dermatitis	0.00012	0.000377	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000119	0.000374	CcSEcCtD
Zuclopenthixol—Nausea—Prednisolone—atopic dermatitis	0.000119	0.000374	CcSEcCtD
Zuclopenthixol—Pruritus—Dexamethasone—atopic dermatitis	0.000119	0.000371	CcSEcCtD
Zuclopenthixol—Pruritus—Betamethasone—atopic dermatitis	0.000119	0.000371	CcSEcCtD
Zuclopenthixol—Vomiting—Triamcinolone—atopic dermatitis	0.000118	0.000368	CcSEcCtD
Zuclopenthixol—Vomiting—Methylprednisolone—atopic dermatitis	0.000117	0.000367	CcSEcCtD
Zuclopenthixol—Nausea—Hydrocortisone—atopic dermatitis	0.000117	0.000365	CcSEcCtD
Zuclopenthixol—Rash—Triamcinolone—atopic dermatitis	0.000117	0.000365	CcSEcCtD
Zuclopenthixol—Dermatitis—Triamcinolone—atopic dermatitis	0.000116	0.000364	CcSEcCtD
Zuclopenthixol—Rash—Methylprednisolone—atopic dermatitis	0.000116	0.000364	CcSEcCtD
Zuclopenthixol—Dermatitis—Methylprednisolone—atopic dermatitis	0.000116	0.000364	CcSEcCtD
Zuclopenthixol—Headache—Triamcinolone—atopic dermatitis	0.000116	0.000362	CcSEcCtD
Zuclopenthixol—Headache—Methylprednisolone—atopic dermatitis	0.000116	0.000362	CcSEcCtD
Zuclopenthixol—Abdominal pain—Prednisone—atopic dermatitis	0.000115	0.000361	CcSEcCtD
Zuclopenthixol—Body temperature increased—Prednisone—atopic dermatitis	0.000115	0.000361	CcSEcCtD
Zuclopenthixol—Diarrhoea—Dexamethasone—atopic dermatitis	0.000115	0.000359	CcSEcCtD
Zuclopenthixol—Diarrhoea—Betamethasone—atopic dermatitis	0.000115	0.000359	CcSEcCtD
Zuclopenthixol—Dizziness—Dexamethasone—atopic dermatitis	0.000111	0.000347	CcSEcCtD
Zuclopenthixol—Dizziness—Betamethasone—atopic dermatitis	0.000111	0.000347	CcSEcCtD
Zuclopenthixol—Nausea—Triamcinolone—atopic dermatitis	0.00011	0.000344	CcSEcCtD
Zuclopenthixol—Nausea—Methylprednisolone—atopic dermatitis	0.00011	0.000343	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisone—atopic dermatitis	0.000108	0.000337	CcSEcCtD
Zuclopenthixol—Vomiting—Betamethasone—atopic dermatitis	0.000107	0.000334	CcSEcCtD
Zuclopenthixol—Vomiting—Dexamethasone—atopic dermatitis	0.000107	0.000334	CcSEcCtD
Zuclopenthixol—Rash—Dexamethasone—atopic dermatitis	0.000106	0.000331	CcSEcCtD
Zuclopenthixol—Rash—Betamethasone—atopic dermatitis	0.000106	0.000331	CcSEcCtD
Zuclopenthixol—Dermatitis—Betamethasone—atopic dermatitis	0.000106	0.000331	CcSEcCtD
Zuclopenthixol—Dermatitis—Dexamethasone—atopic dermatitis	0.000106	0.000331	CcSEcCtD
Zuclopenthixol—Headache—Betamethasone—atopic dermatitis	0.000105	0.000329	CcSEcCtD
Zuclopenthixol—Headache—Dexamethasone—atopic dermatitis	0.000105	0.000329	CcSEcCtD
Zuclopenthixol—Asthenia—Prednisone—atopic dermatitis	0.000105	0.000328	CcSEcCtD
Zuclopenthixol—Pruritus—Prednisone—atopic dermatitis	0.000103	0.000323	CcSEcCtD
Zuclopenthixol—Diarrhoea—Prednisone—atopic dermatitis	9.99e-05	0.000313	CcSEcCtD
Zuclopenthixol—Nausea—Dexamethasone—atopic dermatitis	9.96e-05	0.000312	CcSEcCtD
Zuclopenthixol—Nausea—Betamethasone—atopic dermatitis	9.96e-05	0.000312	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisone—atopic dermatitis	9.66e-05	0.000302	CcSEcCtD
Zuclopenthixol—Vomiting—Prednisone—atopic dermatitis	9.29e-05	0.000291	CcSEcCtD
Zuclopenthixol—Rash—Prednisone—atopic dermatitis	9.21e-05	0.000288	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisone—atopic dermatitis	9.2e-05	0.000288	CcSEcCtD
Zuclopenthixol—Headache—Prednisone—atopic dermatitis	9.15e-05	0.000286	CcSEcCtD
Zuclopenthixol—Nausea—Prednisone—atopic dermatitis	8.68e-05	0.000271	CcSEcCtD
Zuclopenthixol—DRD2—Signaling by GPCR—NPS—atopic dermatitis	4.5e-05	0.000778	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CCL5—atopic dermatitis	4.48e-05	0.000774	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL17—atopic dermatitis	4.47e-05	0.000772	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL17—atopic dermatitis	4.46e-05	0.00077	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL5—atopic dermatitis	4.44e-05	0.000767	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	4.44e-05	0.000767	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	4.44e-05	0.000767	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TAC1—atopic dermatitis	4.43e-05	0.000765	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—NPS—atopic dermatitis	4.43e-05	0.000765	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—NPS—atopic dermatitis	4.42e-05	0.000764	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TAC1—atopic dermatitis	4.42e-05	0.000764	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCR3—atopic dermatitis	4.42e-05	0.000763	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL17—atopic dermatitis	4.38e-05	0.000756	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	4.35e-05	0.000752	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCR3—atopic dermatitis	4.34e-05	0.000751	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TAC1—atopic dermatitis	4.34e-05	0.00075	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—NPS—atopic dermatitis	4.34e-05	0.00075	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCR3—atopic dermatitis	4.34e-05	0.000749	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—CXCL8—atopic dermatitis	4.32e-05	0.000746	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.28e-05	0.00074	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CCR5—atopic dermatitis	4.26e-05	0.000736	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	4.25e-05	0.000735	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.21e-05	0.000728	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.2e-05	0.000726	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CXCL10—atopic dermatitis	4.2e-05	0.000726	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL5—atopic dermatitis	4.19e-05	0.000723	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	4.13e-05	0.000714	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	4.13e-05	0.000713	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.13e-05	0.000713	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL5—atopic dermatitis	4.12e-05	0.000712	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL5—atopic dermatitis	4.11e-05	0.00071	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NPS—atopic dermatitis	4.09e-05	0.000707	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TAC1—atopic dermatitis	4.09e-05	0.000707	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CCL5—atopic dermatitis	4.07e-05	0.000703	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	4.07e-05	0.000702	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—KIF3A—atopic dermatitis	4.05e-05	0.000699	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CCR5—atopic dermatitis	4.04e-05	0.000698	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	4.03e-05	0.000697	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	4.03e-05	0.000696	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	4.03e-05	0.000696	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCR3—atopic dermatitis	4.01e-05	0.000693	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—KIF3A—atopic dermatitis	3.98e-05	0.000688	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—KIF3A—atopic dermatitis	3.97e-05	0.000687	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	3.95e-05	0.000683	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCR3—atopic dermatitis	3.95e-05	0.000683	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.93e-05	0.000679	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	3.9e-05	0.000674	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CXCL10—atopic dermatitis	3.87e-05	0.000668	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.86e-05	0.000667	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.83e-05	0.000662	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL5—atopic dermatitis	3.8e-05	0.000657	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	3.79e-05	0.000654	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	3.75e-05	0.000647	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—CXCL8—atopic dermatitis	3.67e-05	0.000635	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CCR5—atopic dermatitis	3.67e-05	0.000633	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL11—atopic dermatitis	3.66e-05	0.000632	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CMA1—atopic dermatitis	3.66e-05	0.000632	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	3.62e-05	0.000626	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CCL5—atopic dermatitis	3.62e-05	0.000625	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL11—atopic dermatitis	3.6e-05	0.000622	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CMA1—atopic dermatitis	3.6e-05	0.000622	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL11—atopic dermatitis	3.59e-05	0.000621	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CMA1—atopic dermatitis	3.59e-05	0.000621	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCL10—atopic dermatitis	3.57e-05	0.000617	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	3.53e-05	0.000609	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	3.53e-05	0.000609	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TAC1—atopic dermatitis	3.52e-05	0.000609	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NPS—atopic dermatitis	3.52e-05	0.000609	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	3.52e-05	0.000608	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCL10—atopic dermatitis	3.51e-05	0.000607	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—IL2—atopic dermatitis	3.51e-05	0.000607	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCL10—atopic dermatitis	3.5e-05	0.000605	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCR3—atopic dermatitis	3.45e-05	0.000597	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—STAT6—atopic dermatitis	3.44e-05	0.000595	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	3.44e-05	0.000594	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—IL6—atopic dermatitis	3.43e-05	0.000592	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—STAT6—atopic dermatitis	3.39e-05	0.000585	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CCL5—atopic dermatitis	3.38e-05	0.000585	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—STAT6—atopic dermatitis	3.38e-05	0.000584	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GLB1—atopic dermatitis	3.37e-05	0.000582	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NGF—atopic dermatitis	3.35e-05	0.000579	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—CXCL8—atopic dermatitis	3.34e-05	0.000576	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CCL5—atopic dermatitis	3.33e-05	0.000575	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CCL5—atopic dermatitis	3.32e-05	0.000574	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	3.32e-05	0.000573	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	3.28e-05	0.000566	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	3.28e-05	0.000566	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL5—atopic dermatitis	3.28e-05	0.000566	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	3.26e-05	0.000563	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	3.26e-05	0.000563	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CCR5—atopic dermatitis	3.26e-05	0.000563	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCL10—atopic dermatitis	3.24e-05	0.000561	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ADSL—atopic dermatitis	3.23e-05	0.000558	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	3.21e-05	0.000554	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—CXCL8—atopic dermatitis	3.2e-05	0.000553	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.2e-05	0.000552	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	3.19e-05	0.000552	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.19e-05	0.000551	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL2—atopic dermatitis	3.19e-05	0.000551	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	3.14e-05	0.000543	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.13e-05	0.000541	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	3.08e-05	0.000532	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	3.07e-05	0.000531	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	3.05e-05	0.000527	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	3.03e-05	0.000523	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	3.02e-05	0.000522	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCL5—atopic dermatitis	3.02e-05	0.000521	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	3e-05	0.000518	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CCR5—atopic dermatitis	2.99e-05	0.000517	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR3—atopic dermatitis	2.98e-05	0.000516	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	2.96e-05	0.000511	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	2.94e-05	0.000507	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	2.94e-05	0.000507	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR3—atopic dermatitis	2.93e-05	0.000506	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	2.92e-05	0.000504	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	2.88e-05	0.000497	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—CXCL8—atopic dermatitis	2.84e-05	0.00049	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCL5—atopic dermatitis	2.79e-05	0.000482	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	2.79e-05	0.000482	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	2.77e-05	0.000478	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NFKBIA—atopic dermatitis	2.76e-05	0.000477	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	2.75e-05	0.000475	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	2.73e-05	0.000471	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	2.72e-05	0.000471	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	2.72e-05	0.00047	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—IL2—atopic dermatitis	2.71e-05	0.000468	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	2.67e-05	0.000462	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	2.67e-05	0.000461	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TAC1—atopic dermatitis	2.66e-05	0.00046	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NPS—atopic dermatitis	2.66e-05	0.00046	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NPS—atopic dermatitis	2.62e-05	0.000452	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	2.62e-05	0.000452	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TAC1—atopic dermatitis	2.61e-05	0.000451	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NPS—atopic dermatitis	2.61e-05	0.000451	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	2.61e-05	0.000451	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NGF—atopic dermatitis	2.59e-05	0.000447	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CXCL8—atopic dermatitis	2.57e-05	0.000445	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	2.57e-05	0.000443	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	2.56e-05	0.000443	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	2.56e-05	0.000443	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	2.56e-05	0.000442	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCR5—atopic dermatitis	2.52e-05	0.000435	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	2.51e-05	0.000434	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IL2—atopic dermatitis	2.49e-05	0.000431	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	2.48e-05	0.000428	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL5—atopic dermatitis	2.47e-05	0.000427	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL2—atopic dermatitis	2.46e-05	0.000425	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.44e-05	0.000422	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL5—atopic dermatitis	2.43e-05	0.00042	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL5—atopic dermatitis	2.43e-05	0.000419	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCL5—atopic dermatitis	2.4e-05	0.000415	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	2.38e-05	0.000412	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	2.38e-05	0.000411	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	2.38e-05	0.000411	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	2.33e-05	0.000403	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	2.33e-05	0.000403	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NGF—atopic dermatitis	2.23e-05	0.000385	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	2.22e-05	0.000383	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	2.21e-05	0.000382	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCR5—atopic dermatitis	2.17e-05	0.000374	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	2.13e-05	0.000369	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL2—atopic dermatitis	2.12e-05	0.000366	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	2.11e-05	0.000364	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	2.07e-05	0.000358	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	2.07e-05	0.000358	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	2.03e-05	0.000351	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	1.97e-05	0.00034	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	1.89e-05	0.000326	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL2—atopic dermatitis	1.88e-05	0.000325	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—atopic dermatitis	1.87e-05	0.000324	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.84e-05	0.000318	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	1.84e-05	0.000317	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL5—atopic dermatitis	1.81e-05	0.000314	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.81e-05	0.000313	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.81e-05	0.000313	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	1.79e-05	0.000309	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL5—atopic dermatitis	1.78e-05	0.000308	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.78e-05	0.000307	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	1.76e-05	0.000304	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	1.75e-05	0.000302	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	1.73e-05	0.0003	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	1.73e-05	0.000299	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	1.73e-05	0.000299	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	1.7e-05	0.000293	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NGF—atopic dermatitis	1.68e-05	0.00029	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PPARA—atopic dermatitis	1.68e-05	0.00029	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	1.67e-05	0.000289	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NGF—atopic dermatitis	1.65e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NGF—atopic dermatitis	1.65e-05	0.000285	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.65e-05	0.000285	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	1.65e-05	0.000284	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	1.64e-05	0.000284	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR5—atopic dermatitis	1.64e-05	0.000283	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	1.62e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	1.62e-05	0.00028	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	1.61e-05	0.000279	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	1.61e-05	0.000278	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR5—atopic dermatitis	1.61e-05	0.000277	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2—atopic dermatitis	1.6e-05	0.000276	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	1.58e-05	0.000272	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	1.58e-05	0.000272	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	1.57e-05	0.000272	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2—atopic dermatitis	1.57e-05	0.000271	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	1.54e-05	0.000266	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	1.52e-05	0.000263	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	1.5e-05	0.00026	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	1.5e-05	0.000259	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	1.46e-05	0.000253	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2—atopic dermatitis	1.45e-05	0.000251	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—atopic dermatitis	1.45e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	1.43e-05	0.000247	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	1.39e-05	0.00024	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	1.36e-05	0.000236	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	1.36e-05	0.000235	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	1.34e-05	0.000231	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	1.34e-05	0.000231	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	1.31e-05	0.000226	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2—atopic dermatitis	1.25e-05	0.000216	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—atopic dermatitis	1.24e-05	0.000215	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	1.24e-05	0.000214	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	1.15e-05	0.000199	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—atopic dermatitis	1.11e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.09e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	9.89e-06	0.000171	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	9.73e-06	0.000168	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	9.71e-06	0.000168	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	9.52e-06	0.000165	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2—atopic dermatitis	9.45e-06	0.000163	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—atopic dermatitis	9.4e-06	0.000162	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2—atopic dermatitis	9.3e-06	0.000161	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2—atopic dermatitis	9.28e-06	0.00016	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	9.25e-06	0.00016	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—atopic dermatitis	9.23e-06	0.000159	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	9.1e-06	0.000157	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	9.06e-06	0.000156	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	8.85e-06	0.000153	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	8.7e-06	0.00015	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	8.56e-06	0.000148	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—atopic dermatitis	8.54e-06	0.000148	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	8.54e-06	0.000148	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	8.46e-06	0.000146	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	8.41e-06	0.000145	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	8.38e-06	0.000145	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	7.78e-06	0.000134	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—atopic dermatitis	7.35e-06	0.000127	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—atopic dermatitis	5.55e-06	9.59e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—atopic dermatitis	5.46e-06	9.44e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—atopic dermatitis	5.45e-06	9.42e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	5.35e-06	9.24e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	4.97e-06	8.59e-05	CbGpPWpGaD
